Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ALVOW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.22
N/A
NA
vs NA
Q4.22
N/A
NA
vs NA
Q1.23
N/A
NA
vs NA
Q2.23
N/A
NA
vs NA
Q3.23
N/A
NA
vs NA
Q4.23
N/A
NA
vs NA
Q1.24
N/A
NA
vs NA
Q2.24
N/A
NA
vs NA
Q3.24
N/A
NA
vs NA
Q4.24
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q4.22
-31%
23.9M vs 34.8M
Q1.23
+3410%
15.9M vs 452K
Q2.23
-89%
4.4M vs 39.7M
Q3.23
-7%
17.8M vs 19.1M
Q4.23
+124%
53.4M vs 23.9M
Q1.24
-22%
12.4M vs 15.9M
Q2.24
+4426%
198.8M vs 4.4M
Q3.24
+478%
102.9M vs 17.8M
Q4.24
+183%
151.2M vs 53.4M
Q1.25
+664%
95M vs 12.4M
Return on Equity
QoQ
Q1.23
+42%
0.42
vs 0.57
Q2.23
-40%
-0.40
vs 0.42
Q3.23
+28%
0.28
vs -0.40
Q4.23
+30%
0.3
vs 0.28
Q1.24
+33%
0.33
vs 0.3
Q2.24
-11%
-0.11
vs 0.33
Q3.24
+3%
0.03
vs -0.11
Q4.24
+16%
0.16
vs 0.03
Institutionnal Ownership
QoQ
Q1.23
17
17
vs 25
-32%
Q2.23
16
16
vs 17
-6%
Q3.23
15
15
vs 16
-6%
Q4.23
14
14
vs 15
-7%
Q1.24
14
14
vs 14
NA
Q2.24
14
14
vs 14
NA
Q3.24
12
12
vs 14
-14%
Q4.24
12
12
vs 12
NA
Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.
NASDAQ
0.02Â ( 1.43%)
Relative Strenght
10
Volume Buzz
-100%
Earning Acce
No
Dist 52w H.
0%Quote Panel
Key Metrics
Forecast
325%2025-Revenue
-217%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
ALVOW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How ALVOW compares to sector?